News
FDA approves pirtobrutinib for r/r mantle cell lymphoma
- Author:
- Sharon Worcester, MA
Pirtobrutinib for relapsed or refractory mantle cell lymphoma has been approved by the Food and Drug Administration.
News
FDA calls for withdrawal of multiple myeloma drug Pepaxto
- Author:
- Sharon Worcester, MA
A confirmatory trial to show clinical benefit raised concerns about safety.
News
Fungi inside cancer cells: ‘A new and emerging hallmark’
- Author:
- Sharon Worcester, MA
Fungi were detected in all cancer types studied and were often intracellular.
News
One-third of pancreatic cancer diagnoses missed on scans
- Author:
- Sharon Worcester, MA
The time window for curative surgery is often short, and missing the diagnosis can result in worse clinical outcomes.
News
Cost paramount when choosing metastatic breast cancer treatment
- Author:
- Sharon Worcester, MA
“Our analysis provides quantifiable evidence to help providers choose lower priced, but equally effective sequences of drugs.”
News
Experts sound alarm on ruling threatening preventive cancer care
- Author:
- Sharon Worcester, MA
Experts are concerned that the ruling will force some individuals to pay out of pocket for preventive cancer screenings.
News
FDA warns of cancer risk in scar tissue around breast implants
- Author:
- Sharon Worcester, MA
This issue differs from breast implant–associated anaplastic large-cell lymphoma, a known risk among implant recipients.
News
Drinking black tea linked to lower risk of dying from cardiovascular disease
- Author:
- Sharon Worcester, MA
“While these findings may offer reassurance to tea drinkers, they do not indicate that people should start drinking tea or change their tea...
News
After cancer, abortion experience highlights post-Roe reality
- Author:
- Sharon Worcester, MA
- Victoria Stern, MA
A 2021 study found the rate of maternal mortality was almost two times higher in states that restricted abortion access compared with those that...
News
FDA warning: Lymphoma drug heightens risk of death
- Author:
- Sharon Worcester, MA
FDA alert warns of increased risk of death and serious side affects with duvelisib, approved in 2018 to treat adults with CLL or SLL whose two...
News
ctDNA identifies patients with colon cancer who can skip chemo
- Author:
- Sharon Worcester, MA
“The strategy of using ctDNA results to inform treatment almost halved the number of patients who received chemotherapy postsurgery.”